Home › Funds › GREAT POINT PARTNERS LLC › ANNX
GREAT POINT PARTNERS LLC position in ANNX
ANNEXON INC · Health Care
GREAT POINT PARTNERS LLC reported holding 3,500,000 shares of ANNX (ANNEXON INC) in its Q2 2026 13F filing — a position valued at US$20.0M, representing 4.20% of its reported portfolio and ranking #10 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed ANNX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's ANNX position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in ANNX in Q1 2026 at 2,500,000 shares (US$13.8M). The position peaked in Q2 2026 at 3,500,000 shares, worth US$20.0M. Across 2 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,500,000 shares valued at US$20.0M — an increase of 1,000,000 shares quarter over quarter.. Notable position changes include a 40% increase in Q2 2026 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.50M | $13.85M | New |
| Q2 2026 | 3.50M | $19.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANNX and 13F data
ANNX (ANNEXON INC) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), BVF INC/IL (US$49.7M), MAK CAPITAL ONE LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- BVF INC/IL 8.70M sh · $49.67M · Q2 2026
- MAK CAPITAL ONE LLC 5.86M sh · $33.47M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- Bellevue Group AG 4.10M sh · $23.41M · Q2 2026
- MPM BioImpact LLC 3.54M sh · $20.24M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Opaleye Management Inc. 1.71M sh · $9.79M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held ANNX?
GREAT POINT PARTNERS LLC has disclosed ANNX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is GREAT POINT PARTNERS LLC's current position in ANNX?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 3.50M shares of ANNX (ANNEXON INC), valued at $19.98M, representing 4.20% of its reported portfolio and ranking #10.
Has GREAT POINT PARTNERS LLC been buying or selling ANNX?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC increased its position in ANNX. The position peaked in Q2 2026 at 3.50M shares.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, MAK CAPITAL ONE LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.